Full text
| |
| Author(s): |
Ivan José Santana Santos
Total Authors: 1
|
| Document type: | Master's Dissertation |
| Press: | Campinas, SP. |
| Institution: | Universidade Estadual de Campinas (UNICAMP). Faculdade de Engenharia de Alimentos |
| Defense date: | 2012-06-06 |
| Examining board members: |
Lúcia Regina Durrant;
Isis Serrano Silva;
Rose Marry Araujo Gondim Tomaz
|
| Advisor: | Alexandre Nunes Ponezi; Lúcia Regina Durrant |
| Abstract | |
17a-ethinylestradiol (EE2), carbamazepine (CBZ) and ibuprofen (IBU) are pharmaceutical drugs used worldwide and have been frequently detected in wastewater treatment plants and in natural waters in several countries, including Brazil. The major concern about the occurrence of these drugs in trace amounts in drinking water and aquatic environments are the potential adverse effects on human and animal health. The main objective of this study was to assess the potential of ligninolytic fungi and bacteria to degrade these 3 compounds individually. Bacteria and ligninolytic fungi strains were grown on mineral medium with these drugs and with or without glucose. A selection was carried out to choose bacterial and fungal strains with capacity to degrade these drugs and if an addition of a carbon source (glucose) was needed for degradation. Strains with greater capacity to degrade these compounds were selected and assays were performed in order to optimize the incubation time to obtain the highest degradation rate in the shortest incubation time. Subsequently, the enzymatic activities of laccase, lignin peroxidase (LiP) and manganese peroxidase (MnP) produced by the selected fungi was assessed. Also, the action of these enzymes in the degradation of the drugs was evaluated. The involvement of cytochrome P450 enzymes in degradation of the pharmaceutical drugs was evaluated by the addition of piperonyl butoxide (PB), which inhibits this enzyme complex. The toxicity of the drugs and metabolites to Vibrio fischeri were also evaluated. The quantification of the drugs was performed by high performance liquid chromatography. EE2 was completely degraded by all fungi without glucose in the medium, however none of the studied bacteria was capable to degrade it significantly. Pleurotus ostreatus (Jacq.) P. Kumm strain P1 was selected for subsequent tests. The maximum enzyme activity produced by P1 was 5122.11 UL-1 for MnP after 6 days and 307.69 UL-1 for lacase after 4 days, while LiP activity was not detected. Although the detection of the enzymes activity, they were not able to degrade EE2 without the fungal mycelia. Toxicity studies showed the half maximal effective concentration (EC50) value equal to 76% to EE2 prior to fungal treatment, after this no toxicity was observed. Trametes sp. strain BNI was selected to degrade CBZ, and glucose was shown to be necessary for the biodegradation process. After 28 days of incubation, 42% of CBZ was degraded. The maximum laccase activity was 1740.17 UL-1, after 21 days of incubation. LiP maximum activity was 663.08 UL-1, found after 14 days of incubation, while MnP activity was not detected. There was no CBZ degradation using only the enzymatic supernatant. The addition of PB completely inhibited the degradation of CBZ. CBZ and its metabolites did not show toxicity. IBU was completely degraded by all fungi without glucose in the medium, and Trametes sp. strain BNI was selected for further analyses. 17a-ethinylestradiol (EE2), carbamazepine (CBZ) and ibuprofen (IBU) are pharmaceutical drugs used worldwide and have been frequently detected in wastewater treatment plants and in natural waters in several countries, including Brazil. The major concern about the occurrence of these drugs in trace amounts in drinking water and aquatic environments are the potential adverse effects on human and animal health. The main objective of this study was to assess the potential of ligninolytic fungi and bacteria to degrade these 3 compounds individually. Bacteria and ligninolytic fungi strains were grown on mineral medium with these drugs and with or without glucose. A selection was carried out to choose bacterial and fungal strains with capacity to degrade these drugs and if an addition of a carbon source (glucose) was needed for degradation. Strains with greater capacity to degrade these compounds were selected and assays were performed in order to optimize the incubation time to obtain the highest degradation rate in the shortest incubation time. Subsequently, the enzymatic activities of laccase, lignin peroxidase (LiP) and manganese peroxidase (MnP) produced by the selected fungi was assessed. Also, the action of these enzymes in the degradation of the drugs was evaluated. The involvement of cytochrome P450 enzymes in degradation of the pharmaceutical drugs was evaluated by the addition of piperonyl butoxide (PB), which inhibits this enzyme complex. The toxicity of the drugs and metabolites to Vibrio fischeri were also evaluated. The quantification of the drugs was performed by high performance liquid chromatography. EE2 was completely degraded by all fungi without glucose in the medium, however none of the studied bacteria was capable to degrade it significantly. Pleurotus ostreatus (Jacq.) P. Kumm strain P1 was selected for subsequent tests. The maximum enzyme activity produced by P1 was 5122.11 UL-1 for MnP after 6 days and 307.69 UL-1 for lacase after 4 days, while LiP activity was not detected. Although the detection of the enzymes activity, they were not able to degrade EE2 without the fungal mycelia. Toxicity studies showed the half maximal effective concentration (EC50) value equal to 76% to EE2 prior to fungal treatment, after this no toxicity was observed. Trametes sp. strain BNI was selected to degrade CBZ, and glucose was shown to be necessary for the biodegradation process. After 28 days of incubation, 42% of CBZ was degraded. The maximum laccase activity was 1740.17 UL-1, after 21 days of incubation. LiP maximum activity was 663.08 UL-1, found after 14 days of incubation, while MnP activity was not detected. There was no CBZ degradation using only the enzymatic supernatant. The addition of PB completely inhibited the degradation of CBZ. CBZ and its metabolites did not show toxicity. IBU was completely degraded by all fungi without glucose in the medium, and Trametes sp. strain BNI was selected for further analyses (AU) | |
| FAPESP's process: | 10/02947-7 - Study of the potential for biodegradation of 17±-ethinylestradiol, Carbamazepine and Ibuprofen by lignolitics fungi and bacteria. |
| Grantee: | Ivan José Santana Santos |
| Support Opportunities: | Scholarships in Brazil - Master |